Larimar Therapeutics, Inc. (LRMR) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
LRMR Revenue Growth
LRMR Revenue Analysis (2014–2025)
As of May 8, 2026, Larimar Therapeutics, Inc. (LRMR) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, LRMR's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including ACAD (+9.9% YoY), PTCT (-53.3% YoY), and FOLD (+20.0% YoY). Compare LRMR vs ACAD →
LRMR Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| LRMRCurrent | $0 | - | - | - | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% | |
 PTCT | $1.7B | -53.3% | +35.4% | 49.5% | |
 FOLD | $634M | +20.0% | +19.4% | 5.4% | |
 RARE | $673M | +13.3% | +19.9% | -79.5% |
LRMR Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-350,000 | - | $-172,497,000 | - |
| 2024 | $0 | - | $0 | - | $-90,890,000 | - |
| 2023 | $0 | - | $0 | - | $-41,758,000 | - |
| 2022 | $0 | - | $0 | - | $-36,526,000 | - |
| 2021 | $0 | - | $0 | - | $-50,465,000 | - |
| 2020 | $0 | - | $-155,000 | - | $-42,804,000 | - |
| 2019 | $0 | - | $-78,000 | - | $-23,214,000 | - |
| 2018 | $0 | - | $-261,000 | - | $-62,722,000 | - |
| 2017 | $0 | - | $-188,000 | - | $-53,875,000 | - |
| 2016 | $0 | - | $-212,000 | - | $-57,122,000 | - |
See LRMR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LRMR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LRMR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLRMR — Frequently Asked Questions
Quick answers to the most common questions about buying LRMR stock.
Is LRMR's revenue growth accelerating or slowing?
LRMR TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is LRMR's long-term revenue growth rate?
Larimar Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is LRMR's revenue distributed by segment?
LRMR reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.